Social Behavior in Depression (HLGDep)

February 4, 2018 updated by: ma, yina, Beijing Normal University
In the project, investigators basically plan to test the difference in social behavior and social cognition between depressive patients and healthy individuals. To test this, investigators plan to use traditional or novel behavioral experiment paradigms to target various behaviors.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yina Ma, Doctor
  • Phone Number: +8613810258647
  • Email: yma@bnu.edu.cn

Study Locations

      • Beijing, China
        • Recruiting
        • HuiLongGuan Hospital
        • Contact:
          • Yina Ma, Doctor
        • Principal Investigator:
          • Yina Ma, Doctor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Individuals diagnosed with depression and healthy control

Description

Inclusion Criteria:

  • Age range between 18 and 60
  • Education experience above high school
  • Score for Hamilton's Depression Scale >=17
  • Diagnosis of depression through Scid

Exclusion Criteria:

  • Undergoing electric shock treatment in 3 months
  • Excluding those who with bipolar disorder
  • Excluding those who with postpartum depression
  • Excluding those who with hysteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prosocial behavior
Time Frame: Baseline
The prosocial behavior will be assessed by conventional economic games, including dictator game, message game, and ultimatum game.
Baseline
Cognitive flexibility
Time Frame: Baseline
Cognitive flexibility will be assessed by psychological cognitive paradigm, i.e. reversal learning paradigm. The participants will be asked to choose the item with high probability to win reward.
Baseline
Valuation of social information
Time Frame: Baseline
The valuation of social information was measured by psychological paradigm, developed from animal studies, called "pay-per-view". The participants will be asked make decision about more social information or more monetary reward.
Baseline
Optimism bias
Time Frame: Baseline
Participants will complete two sessions of life event estimation, i.e. estimating their likelihood of experiencing each event on a self-paced basis.
Baseline
Emotion recognition
Time Frame: Baseline
After viewing a video, participants will be asked to judge the person's attitude in the video. Through this paradigm, investigators could test emotional bias in social interaction in depressive patients.
Baseline
Model-free & model-based tendency
Time Frame: Baseline
Participants will be asked to complete a two-stage task, by choosing the stimuli with high probability to obtain reward.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Yina Ma, Doctor, Beijing Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Anticipated)

February 16, 2018

Study Completion (Anticipated)

March 1, 2018

Study Registration Dates

First Submitted

January 22, 2018

First Submitted That Met QC Criteria

January 26, 2018

First Posted (Actual)

January 30, 2018

Study Record Updates

Last Update Posted (Actual)

February 6, 2018

Last Update Submitted That Met QC Criteria

February 4, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • HLGdepression

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

3
Subscribe